Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

The Health and Human Services Department says the county’s Treatment Court program is ending due to an unfilled key staff ...

Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...

UNAIDS warns that cuts to HIV/AIDS funding by rich donors, including the U.S., have led some poorer nations to boost their ...

Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to hinder his priorities.

Healthcare delivery organizations are saying they have yet to fully recover financially from the COVID-19 pandemic, and a high level of uncertainty around changing regulations and economic conditions ...

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

Hospitals, health systems and physician practices are shifting their operational and financial strategies in the face of ...

(Kime, 7/21) California Healthline: Cuts To Food Benefits Stand In The Way Of RFK Jr.’s Goals For A Healthier National Diet Belinda McLoyd has been thinking about peanut butter. McLoyd, 64, receives a ...

The idea of making the U.S. more like Europe is anathema to many in the Trump administration. But that’s what the Make ...